Is it reasonable for the use of Rh‐ee blood? A hospital‐based survey from a southern medical center in Taiwan-Reference-Cited by-同舟云学术

Is it reasonable for the use of Rh‐ee blood? A hospital‐based survey from a southern medical center in Taiwan

Published:2021-10-14 Issue:1 Volume:38 Page:65-69
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung J of Med Scie

Author:

Hsiao Hui‐Hua¹²³⁴^ORCID,Yeh Chi‐Jung⁵,Ting Shuo‐Chun⁶,Chuang Tzer‐Ming¹,Ke Ya‐Lun¹,Yeh Tsung‐Jang¹²^ORCID,Gau Yu‐Chin¹²^ORCID,Du Jeng‐Shiun¹²,Hsiao Chi‐En¹,Wang Hui‐Ching¹²,Cho Shih‐Feng¹²,Hsu Chin‐Mu¹³,Liu Yi‐Chang¹²⁶^ORCID

Affiliation:

1. Division of Hematology and Oncology, Department of Internal Medicine Kaohsiung Medical University Hospital Kaohsiung Taiwan

2. Faculty of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung Taiwan

3. Center for Liquid Biopsy Kaohsiung Medical University Kaohsiung Taiwan

4. Cancer center Kaohsiung Medical University Hospital Kaohsiung Taiwan

5. Department of Molecular Biology and Cell Research Chang Bing Show Chwan Memorial Hospital Changhua Taiwan

6. Blood bank, Department of laboratory medicine Kaohsiung Medical University Hospital Kaohsiung Taiwan

Funder

Kaohsiung Medical University Chung-Ho Memorial Hospital

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12453

Reference26 articles.

1. Indications for and Adverse Effects of Red-Cell Transfusion

2. Adverse Reactions to Transfusion of Blood Products and Best Practices for Prevention

3. Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study)

4. Red Blood Cell Alloimmunization Mitigation Strategies

5. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions